The price of this share is at 1,86$, Sonnet Biotherapeutics Holdings Inc is a company created in United States dedicated to Biotechnology: Commercial Physical & Biological Resarch with its highest number of sales in North America. Its Executives are John Harry Cross (Chief Financial Officer, Treasurer & Secretary), John K. Cini (Chief Scientific Officer), Manuel Dafonseca (Head-Clinical Operations), Pankaj Mohan (Chairman, President & Chief Executive Officer), Susan Dexter (Chief Technical Officer) and its address is 100 OVERLOOK CENTER SUITE 102, PRINCETON, New Jersey, 8540, United States.
Yesterday this stock ended the day with a value of desconocido$.
With an intraday difference of 1,89$ moving between 1,81$ and 1,97$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last value we have registered for the opening is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
